| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e45efeaa6a34dfd9d44fa29a7fe0c806 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-14 |
| filingDate |
1989-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1990-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71d9ab2a6030f1e04bdf7b58d0b7885f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4b4419fd7d6186aeb81d60dfabac025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41187c6704099c874b6a661e599107cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_974194fdccb5a8553106b3f44fc2fe59 |
| publicationDate |
1990-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4937240-A |
| titleOfInvention |
Thienotriazolodiazepine compounds and pharmaceutical uses thereof |
| abstract |
Thienotriazolodiazepine compounds of the formula: <CHEM> wherein each symbol is as defined in the specification and pharmaceutically acceptable salts thereof, and pharmaceutical uses thereof. Said compounds exhibit PAF-antagonistic activity and are useful for the prevention or treatment of various PAF-induced diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5286858-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5698552-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5104543-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0480455-A1 |
| priorityDate |
1988-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |